Anthrax among heroin users in europe possibly caused by same bacillus anthracis strain since 2000

Eurosurveillance

Volumn 18, Issue 13, 2013, Pages 1-

  Grunow, R ^a   Klee, S R ^a   Beyer, W ^b   George, M ^a   Grunow, D ^a   Barduhn, A ^a   Klar, S ^a   Jacob, D ^a   Elschner, M ^c   Sandven, P ^d   Kjerulf, A ^e   Jensen, J S ^e   Cai, W ^a   Zimmermann, R ^a   Schaade, L ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; DIAMORPHINE;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; RETROSPECTIVE STUDY; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; WESTERN BLOTTING;

EID: 84875664999     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hugh-Jones M, Blackburn J. The ecology of Bacillus anthracis. Mol Aspects Med. 2009;30(6):356-67. http://dx.doi.org/10.1016/j.mam.2009.08.003. PMid:19720074.
2. World Organisation for Animal Health (OIE), World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAOAnthrax in humans and animals. Fourth edition.Geneva: WHO; 2008.
3. Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med. 2012;38(7):1092-104. http://dx.doi.org/10.1007/s00134-012-2541-0. PMid:22527064. PMCid:3523299.
4. Health Protection Scotland (HPS), National Services Scotland (NHS). An Outbreak of Anthrax Among Drug Users in Scotland, December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team. Glasgow: HPS. Available from: http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf
5. Jallali N, Hettiaratchy S, Gordon AC, Jain A. The surgical management of injectional anthrax. J Plast Reconstr Aesthet Surg. 2011;64(2):276-7. http://dx.doi.org/10.1016/j.bjps.2010.06.003. PMid:20615773.
6. Grunow R, Verbeek L, Jacob D, Holzmann T, Birkenfeld G, Wiens D, et al. Injection Anthrax-a New Outbreak in Heroin Users. Dtsch Arztebl Int. 2012;109(49):843-8. PMid:23267409. PMCid:3528063.
7. Knox D, Murray G, Millar M, Hamilton D, Connor M, Ferdinand RD, et al. Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis. J Bone Joint Surg Br. 2011;93(3):414-7. http://dx.doi.org/10.1302/0301-620X.93B3.25976. PMid:21357967.
8. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. Am J Respir Crit Care Med. 2011;184(12):1333-41. http://dx.doi.org/10.1164/rccm.201102-0209CI. PMid:21852539. PMCid:3361358.
9. Booth MG, Hood J, Brooks TJ, Hart A. Anthrax infection in drug users. Lancet. 2010;375(9723):1345-6. http://dx.doi.org/10.1016/S0140-6736(10)60573-9
10. European Centre for Disease Prevention and Control (ECDC). Epidemiological update: anthrax cases among people who inject drugs. Stockholm: ECDC. 8 Mar 2013. Available from: http://ecdc.europa.eu/en/press/news/Lists/News/ECDC_DispForm.aspx?List=32e43ee8-e230-4424-a783-85742124029a&ID=860&RootFolder=%2Fen%2Fpress%2Fnews%2FLists%2FNews
11. German Committee on Biological Agents (ABAS). Technical Rules for Biological Agents 466 - Classification of Prokaryotes (Bacteria and Archaea) into Risk Groups. http://www.baua.de/en/Topics-from-A-to-Z/Biological-Agents/TRBA/pdf/TRBA-466.pdf;jsessionid=935E7A8B0476DCAF3E99BB417056914C.1_cid380?__blob=publicationFile&v=3
12. Spotts Whitney EA, Beatty ME, Taylor TH, Jr., Weyant R, Sobel J, Arduino MJ, et al. Inactivation of Bacillus anthracis spores. Emerg Infect Dis. 2003;9(6):623-7. http://dx.doi.org/10.3201/eid0906.020377.PMCid:3000133.
13. Grunow R, Porsch-Ozcurumez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, et al. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine. 2007;25(18):3679-83. http://dx.doi.org/10.1016/j.vaccine.2007.01.056. PMid:17287051.
14. Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis. 2004;190(7):1228-36. http://dx.doi.org/10.1086/423937. PMid:15346332.
15. Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA, Boyer AE, et al. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis. 2007;44(7):968-71. http://dx.doi.org/10.1086/512372. PMid:17342650.
16. Ringertz SH, Hoiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, et al. Injectional anthrax in a heroin skin-popper. Lancet. 2000;356(9241):1574-5. http://dx.doi.org/10.1016/S0140-6736(00)03133-0.
17. Radun D, Bernard H, Altmann M, Schöneberg I, Bochat V, van Treeck U, et al. Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Euro Surveill. 2010;15(2):pii=19464. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19464. PMid:20085693.
18. Robert Koch-Institut R Ein dritter Fall von Anthrax bei einem i. v. Heroinkonsumenten in Deutschland [Third anthrax case in an injecting heroin user in Germany]. Epidemiologisches Bulletin. 2010;1(49):492-93. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2010/Ausgaben/49_10.pdf?__blob=publicationFile
19. ProMED-mail. Anthrax - Germany (08): (Berlin) ongoing investigations. Archive Number 20120713.1200646. 13 Jul 2012. Available from: http://www.promedmail.org/direct.php?id=1200646
20. ProMED-mail. Anthrax, human - Denmark (03): fatal conf. heroin case. Archive Number 20120709.1195198. 09 Jul 2012. Available from: http://www.promedmail.org/direct.php?id=20120709.1195198
21. ProMED-mail. Anthrax - France: (RA) conf. heroin case. Archive Number 20120714.1201908. 14 Jul 2012. Available from: http://www.promedmail.org/direct.php?id=20120714.1201908
22. ProMED-mail. Anthrax, human - UK (02): (Scotland) new heroin related case, alert. Archive Number 20120725.1214623. 25 Jul 2012. Available from: http://www.promedmail.org/direct.php?id=20120725.1214623
23. ProMED-mail. Anthrax, human - Denmark (04): 2nd heroin associated case. Archive Number 20120727.1217584. 27 Jul 2012. Available from: http://www.promedmail.org/direct.php?id=20120727.1217584
24. ProMED-mail. Anthrax, human - UK (06): (Wales) new heroin case. Archive Number 20120907.1285521. 07 Sep 2012. Available from: http://www.promedmail.org/direct.php?id=20120907.1285521
25. Beyer W, Bellan S, Eberle G, Ganz HH, Getz WM, Haumacher R, et al. Distribution and Molecular Evolution of Bacillus anthracis Genotypes in Namibia. PLoS Negl Trop Dis. 2012;6(3):e1534.
26. Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM, Okinaka R, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol. 2000;182(10):2928-36. http://dx.doi.org/10.1128/JB.182.10.2928-2936.2000. PMid:10781564. PMCid:102004.
27. Lista F, Faggioni G, Valjevac S, Ciammaruconi A, Vaissaire J, le Doujet C, et al. Genotyping of Bacillus anthracis strains based on automated capillary 25-loci multiple locus variable-number tandem repeats analysis. BMC Microbiol. 2006;6:33. http://dx.doi.org/10.1186/1471-2180-6-33. PMid:16600037. PMCid:1479350.
28. Van Ert MN, Easterday WR, Huynh LY, Okinaka RT, Hugh-Jones ME, Ravel J, et al. Global genetic population structure of Bacillus anthracis. PLoS One. 2007;2(5):e461. http://dx.doi.org/10.1371/journal.pone.0000461. PMid:17520020. PMCid:1866244.
29. Price EP, Seymour ML, Sarovich DS, Latham J, Wolken SR, Mason J, et al. Molecular Epidemiologic Investigation of an Anthrax Outbreak among Heroin Users, Europe. Emerg Infect Dis. 2012;18(8):1307-13. http://dx.doi.org/10.3201/eid1808.111343. PMid:22840345. PMCid:3414016.
30. Beyer W, Turnbull P. Anthrax in animals. Mol Aspects Med. 2009;30(6):481-9. http://dx.doi.org/10.1016/j.mam.2009.08.004. PMid:19723532.
31. Beyer W, J. Lazak, K. Hilss, R. Böhm Stability tests of 31 VNTR markers in routine diagnostics (Poster at Bacillus anthracis, B. cereus and B. thuringiensis International Conference). Bacillus anthracis, B cereus and B thuringiensis International Conference, August 30 - September 3, Santa Fe, USA, Abstract book, p 45. 2009.
32. Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill. 2012;17(26):pii=20204. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20204. PMid:22790532.
33. Kissling E, Wattiau P, China B, Poncin M, Fretin D, Pirenne Y, et al. Banthracis in a wool-processing factory: seroprevalence and occupational risk. Epidemiol Infect. 2012;140(5):879-86. http://dx.doi.org/10.1017/S0950268811001488. PMid:21835070.
34. Wattiau P, Govaerts M, Frangoulidis D, Fretin D, Kissling E, Van Hessche M, et al. Immunologic response of unvaccinated workers exposed to anthrax, Belgium. Emerg Infect Dis. 2009;15(10):1637-40. http://dx.doi.org/10.3201/eid1510.081717. PMid:19861061. PMCid:2866386.